SYS-CON MEDIA Authors: Peter Silva, Kevin Jackson, Jessica Qiu, Dana Gardner, Dan Stolts

News Feed Item

World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)

NEW YORK, Feb, 11, 2013 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)
http://www.reportlinker.com/p01095493/World-Market-for-Molecular-Diagnostics-5th-Edition-Infectious-Disease-Oncology-Blood-Screening-Pre-Natal-and-Other-Areas-- .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the IVD market. As analyst Shara Rosen, R.T., MBA. details, in recent years years the number of assays introduced has been growing at a remarkable clip. This report, The World Market for Molecular Diagnostics (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas) represents the fifth time that Kalorama has conducted a complete study into the market for molecular diagnostics.

Comprehensive Coverage of the Molecular Diagnostics Industry

The report not only contains current market data for business planning, it goes beyond the numbers to fully assess what is going on in the market and why. Since the last edition of this report, a lot has changed, and a lot has stayed the same. There is intense competition but also opportunities for entrants in some areas. As part of its coverage, the report includes the following:

- Over 800 Pages of Detailed Market Coverage
- Over 55 Tables Makes Market Analysis More Accessible
- Current Market Size and Forecast 2012-2017 for Several Molecular IVD Segments (Infectious Disease, Blood Screening, Histology, Oncology, Prenatal, Coagulation, Tissue Typing, Inherited Diseases, Pharmacodiagnostics and Other)
- Infectious Disease Molecular Sales by Disease (Hepatitis, HIV, GC/Chlamydia, HAI, Respiratory, Organism ID, Mycobacteria/TB, others)
- Over 200 Profiles of Molecular Diagnostic Competitors
- Recent Mergers and Acquisitions
- Revenues of Test Service Companies
- Geographic Breakout of the Molecular Diagnostics Market by Region (North America, Europe, China, Japan, ROW)
- Sample Prep Market, 2012 and 2017
- Breakout of Molecular Histology/Cytology Market (in situ hybridization, HPV, Tissue Microarrays), 2012 and 2017

More and more laboratories offer complex panels of tests that help physicians evaluate disease risk and make therapeutic decisions. Government and private healthcare payers have recognized the value of new molecular tools and have agreed to pay for them. A desire for better and faster test results, a preference for tests that are aimed at the patent, renewed interest in IVD in general and more particularly in molecular IVD has led to the commercialization of a number of technological tools that make more sensitive and specific tests possible. Some of these technological innovations include cost-effective, multiplexed testing platforms coupled with high-powered software capabilities. In addition analyses using saliva, urine, and blood instead of biopsied tissue make for more patient-friendly test systems.

Over 200 Companies Profiled and Ranked

Kalorama provides profiles of over 200 companies participating in the market. All of these companies have different strategies and compete in different areas, and Kalorama acknowledges this by separating the companies in a triage system based on where they stand in the molecular in vitro diagnostics market.

- "IVD Leaders" - The top IVD companies participating in molecular diagnostics as well as dominating the rest of testing.
- "Molecular Diagnostics Leaders" -The top companies focused on molecular testing.
- "Molecular Diagnostics Participants"- Molecular diagnostic companies that are by now established in the market
- "Promising Companies"- Those companies that have potential with an innovative approach
- "Molecular Diagnostics Newcomers"- IVD Companies that have novel or interesting approaches to keep an eye on
- "Platform Innovators"- Companies that have developed new platform technologies
- "Information Technology Companies" - Molecular testing relies on strong information systems to handle data. These companies are in the forefront.
- "Sample Prep Leaders" - Companies focused on sample preparation for molecular diagnostics
- "Specialist Companies" - In various areas (microbiology, histology, blood banking, etc)

A Realistic Look at The Need-To-Know Trends

Molecular diagnostics is a complicated market that requires a thorough analysis to understand. Many reports make bold predictions which later are proved incorrect by market events. In this report, Kalorama Information provides revenues and market forecasts, but also looks deeply at some of the trends in the market and what might impact results in the future. The report summarizes what is working and what is not working in the past few years.

- Sequencing Hype and Reality: Innovations in DNA Sequencing, Key Players and its Future in Clinical Medicine
- Pharmacodiagnostics and Where it Stands in 2013
- The Latest Growth Numbers of LDTs, regulatory activity, and their impact on the Market
- IVD Directive Update
- Patent Issues
- Healthcare Reform, Accountable Care Organizations and Reimbursement Trends
- Improvements in Platforms
- Developments in ISH testing, Tissue Microarrays and Mass Spectroscopy
- Integrated Sample-to-Results Testing

Market size and forecasts in the report are for manufacturer's revenues. Secondary and primary resources, including: trade publications, annual report and interviews with key executives in molecular diagnostics were used for this study.

CHAPTER ONE: EXECUTIVE SUMMARY
Introduction
Scope and Methodology
Size and Growth of the Market
Market Trends

CHAPTER TWO: INTRODUCTION
Background

Developments since 2000
New Platforms
Test Quality Control


Building a Strong Future

The Service Industry Makes Gains
The $1000 Genome
Information Technology and "Apps"
Miniaturization and Multiplexed Assays
Integrated Sample–to-Results Testing
Mass Spectrometry


Tests and Technologies in 2012

CHAPTER THREE: THE COMMERCIALIZATION CONUNDRUM
Background
Commercialization of Molecular Tests
Regulatory Issues and Molecular Assays
Patent Litigation Abounds

Consumer, Payer and Physician Acceptance
Clinical Molecular Test Reimbursement Coding in The U.S.

CHAPTER FOUR: SEQUENCING – HYPE AND REALITY
Background

Companies and Technologies
PCR Not Ready To Take the Back Seat
Pathogen sequencing
Prenatal Fetal Chromosomal Analysis

CHAPTER FIVE: MARKET ANALYSIS: WORLD MARKETS
Background
Market Estimate and Forecast by Region
The United States

RUO/IUO Issues
The Patient Protection and Affordable Care Act
Accountable Care Organizations


Europe

IVD Directive Update


China
India

CHAPTER SIX: THE MARKET FOR BLOOD MARKERS IN CANCER
Overview

Methylation Patterns
Other Tests


Blood Molecular Test Market and Forecasts

LDTs
Radiotherapy Testing

CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY
Flow Cytometry

CHAPTER EIGHT: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE
Thrombophilia SNPs

MTHFR
Factor V
CYP4V2
Market and Forecast
Coagulation Molecular Research Projects


Pharmacodiagnostics

Market for PGx testing
Plavix Testing

CHAPTER NINE: HISTOLOGY AND CYTOLOGY
Overview
in situ hybridization
HPV Testing

Tissue Microarrays
Circulating Tumor Cells
Chromosome Analysis
Pharmacodiagnostic Histology

CHAPTER TEN: MICROBIOLOGY AND VIROLOGY
Overview
Microbiology Market and Forecast

Role of ID Testing in the Molecular Diagnostics Market
Markets for Specific Infectious Disease Tests


Genome Sequencing

Roche, Illumina and Life
Other Systems


Mass Spectrometry

Major Companies
Market Estimate


Blood Culture

HIV
Market and Forecast


Hepatitis

Market and Forecast
Sexually Transmitted Diseases (STDs)
Hospital Acquired Infections (HAIs)
Market and Forecast
Respiratory Tract Infections


Tuberculosis

Market and Forecast


Fungal Infections

CHAPTER ELEVEN: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION MEDICINE
Blood Pathogen Screening

Market and Forecast


Blood Typing

Molecular Blood Typing

CHAPTER TWELVE: THE MARKET FOR MOLECULAR ASSAYS IN ORGAN TRANSPLANT MANAGEMENT
HLA Typing

Stem Therapy Matching
HLA Market and Forecast

CHAPTER THIRTEEN: THE MARKET FOR MOLECULAR ASSAYS IN PRENATAL AND NEONATAL TESTING
Overview
Market and Forecast
FISH testing

Other Developments


Neonatal Testing


CHAPTER FOURTEEN: THE MARKET FOR MOLECULAR ASSAYS FOR INHERITED DISEASES
Arthritis
Gastrointestinal Conditions
Diabetes
Cardiovascular Disease
Alzheimer's Disease
Parkinson's Disease
Psychiatric Disorders
Autism


CHAPTER FIFTEEN: CONCLUSIONS AND STRATEGIC IMPLICATIONS – 2012 AND BEYOND
Expectations and Realities
Four Issues That Will Impact Market Success


CHAPTER SIXTEEN: COMPETITIVE ANALYSIS
Companies and Vendors to Watch
Acquisitions, Alliances and Collaborations
Looking Beyond Borders


CHAPTER SEVENTEEN: COMPANY PROFILES: TOP TIER IVD COMPANIES' MOLECULAR BUSINESSES
Abbott Diagnostics

Recent Revenue History
HLA
Molecular Histology
Companion Tests
Molecular Diagnostics
Infectious Diseases - Molecular
IntelligentMDx Alliance
PLEX-ID


Alere

Recent Revenue History
ARKRAY


Beckman Coulter Inc./Danaher Fullerton, CA www.beckmancoulter.com

Recent Revenue History
Instrumentation


Becton, Dickinson and Company (BD)

Recent Revenue History
The BD MAX Enterprise
Viper System
Molecular Microbiology
BD GeneOhm
Histology
Oncology, etc.


bioMerieux Inc.

Recent Revenue History
Molecular Oncology
The Biocartis Program
Molecular Microbiology
NucliSENS
Product Development


Bio-Rad Laboratories Inc.

Recent Revenue History


Gen-Probe Inc.

Recent Revenue History
Product development
Expansion
Prostate Cancer
STDs
Panther System
HPV
Transplant/HLA testing
Infectious Diseases
Blood Bank


Hologic, Inc.

Recent Revenue History


Instrumentation Laboratory (IL)

Recent Revenue History


Ortho Clinical Diagnostics

Recent Revenue History


QIAGEN N.V.

Recent Revenue History
Market Expansion
Histology
Infectious diseases
Rotor-Gene
Oncology/Personalized Medicine
TB
HPV
HLA
Automation for the Future
Women's Health
Point of Care
Sequencing


Roche Diagnostics Indianapolis, IN www.roche.com

Recent Revenue History
Miscellaneous
Viral Load
STDs
Companion Tests
Sample Preparation
Tissue Diagnostics
Blood Bank
Sequencing
Microarrays


Siemens Healthcare Diagnostics

Recent Revenue History
Histology
Molecular
Sequencing
Companion Tests


Sysmex Corporation

Recent Revenue History


Thermo Fisher Scientific Inc.

Recent Revenue History
Allergy

CHAPTER EIGHTEEN: COMPANY PROFILES: MAJOR MOLECULAR TEST COMPANIES
Affymetrix, Inc.

Histology
Whole Genome Analysis


Agilent Technologies Inc.

Research Products


Asuragen, Inc.

Oncology
Inherited Diseases
Controls
Sample Collection
Sequencing


Beijing Genome Institute (BGI)

BGI Projects


BioFire Diagnostics, Inc.

Respiratory Panel
Environmental Testing


Caliper Life Sciences

Clinical Diagnostics
Sequencing
Life Sciences


Celera Diagnostics
Cepheid

Market Expansion
HAI
Personalized Medicine
TB
Infectious Diseases


Eiken Chemical Co., Ltd
Enzo Biochem Inc.

ColonSentry
Alliances
IP Protection


Epigenomics AG
Fluidigm Corporation

Prenatal


Illumina Inc.

BeadXpress
Sequencing
Cytogenetics
Sample Prep
PCR
CLIA Lab Service


Ipsogen SA
Life Technologies

Ion Torrent Systems
Personalized Medicine
PCR
Arrays
IVD Company Deals
Life and Quidel develop diagnostics on the 7500 Fast Dx
Sepsis
HIV
Informatics
International Presence


Novartis Diagnostics

Blood Bank
International Programs
Blood Typing
Molecular IVDs
Companion Tests


PerkinElmer, Inc.

Prenatal and Neonatal Screening
Personalized Medicine
Molecular and Sequencing Diagnostics
Test Services
Human Health Research


RainDance Technologies, Inc.

Product Development


Seegene, Inc.

Instrumentation


Transgenomic, Inc.

Lab Services
Diagnostic Tools Division
CTCs
Sequencing

CHAPTER NINETEEN: MARKET PARTICIPANTS
Alacris Theranostics GmbH
Astra Biotech GmbH
Autogenomics Inc.
Biocartis SA
Biofortuna Ltd.
Biotype Diagnostic GmbH
BlueGnome
DiaGenic ASA
DiagnoCure
ELITech Group
EraGen Biosciences Inc.
Genetic Technologies Limited
Victoria, Australia
www.gtglabs.com
GenMark Diagnostics Inc.
Helicos BioSciences
IRIS International, Inc.

Cytology


Luminex Corporation

IVD Expansion
Cystic Fibrosis
MAGPIX Multiplexing


Meridian Bioscience, Inc.

Bioline


Nanosphere, Inc.

Infectious Diseases
Hospital Acquired Infections


Sony DADC Biosciences

Cell Sorting
Mass Spectrometry


TrimGen Genetic Technology
TrovaGene, Inc.

Prenatal

CHAPTER TWENTY: PROMISING COMPANIES
Ahram Biosystems, Inc.
Allegro Diagnostics Corp
Amoy Diagnostics Co. Ltd.
Anagnostics Bioanalysis GmbH

Sample Preparation


Applied BioCode, Inc.
ArcticDx Inc.
Ariosa Diagnostics
Axela Inc.
BioHelix Corporation
BioNanomatrix/ BioNano Genomics
BJS Biotechnologies
DiagCor Bioscience Inc. Ltd.
DxTerity Diagnostics Inc.
Epistem plc
Exiqon A/S
Exonhit
GeneNews Limited
Genome Diagnostics BV (GenDx)
Genomica S.A.U.
Genorama Ltd.
Great Basin Corporation
Health Discovery Corporation (HDC)
IncellDx, Inc.
Insight Genetics
IntegenX Inc.

Sample Transport


Linkage Biosciences, Inc.
Med BioGene, Inc. (MBI)
Multiplicom
NABsys, Inc.
Nanostring Technologies, Inc.
NIPD Genetics Ltd
OptiGene Ltd
Orion Genomics
Oxford Gene Technology (OGT)
PrimeraDx
Rheonix Inc.
Skyline Diagnostics B.V.
Spartan Bioscience Inc.
Stratos Genomics Inc.
VolitionRx Limited
WaferGen Biosystems, Inc.

CHAPTER TWENTY ONE: MOLECULAR NEWCOMERS
DiaSorin S.p.A.
Fujirebio Diagnostics, Inc.
GE Healthcare

Cell Imaging
Molecular Sequencing


Phadia AB
Quidel Corporation

Alliances


Randox Laboratories Ltd.
TOSOH Corporation
Transasia Bio-Medicals Ltd.

CHAPTER TWENTY TWO: TEST PLATFORM INNOVATIONS
Advanced Liquid Logic, Inc. (ALL)
Aquila Diagnostic Systems
Canon U.S. Life Sciences (CLS)
DNA Medicine Institute (DMI)
Espira, Inc.
Genia Technologies Inc.
Genisphere
Lumora Ltd.
Michigan State University
NobleGen Biosciences
Oxford Nanopore Technologies Ltd.
QuantuMDx Group Limited
SensiQ Technologies, Inc.
Thermal Gradient, Inc.
Vela Diagnostics (VelaDx)

CHAPTER TWENTY THREE: SAMPLE PREPARATION SUPPLIERS
Arcxis Biotechnologies
Argylla Technologies LLC
Biomatrica, Inc.
Fluoresentric, Inc.
New England Biolabs, Inc. (NEB)
NorDiag
Norgen Biotek Corp.
Phthisis Diagnostics
PreAnalytiX GmbH
QIAGEN N.V.
Streck
ZyGEM Corp. Ltd.

CHAPTER TWENTY FOUR: COMPANY PROFILES: INFORMATION TECHNOLOGY SPECIALISTS
Access Genetics
CLC bio
CollabRx, Inc.
Definiens
DNA Direct
DIYGenomics
GenoSpace, LLC
HolGenTech Inc.
Ingenuity Systems
MediSapiens Ltd.
NextBio
Personalis
Portable Genomics
Sciclips
Selventa
Sophic Systems Alliance
Wellpoint Inc.

CHAPTER TWENTY FIVE: MICROBIOLOGY SPECIALISTS
Advanced Biological Laboratories (ABL)
AdvanDx, Inc.
Akonni Biosystems Inc.

Sample Preparation
Test Systems


Biomagnetics Diagnostics Corporation
BlackBio S.L.
Bruker BioSciences Corporation
CapitalBio Corporation
Ceeram S.A.S.
Cooperative Diagnostics, LLC
Curetis AG
Enigma Diagnostics Limited
Focus Diagnostics, Inc.
GenoID Ltd.
Great Basin Scientific, Inc.
Hain Lifescience GmbH
HiberGene Diagnostics Ltd
Ibis Biosciences
iCubate Incorporated
Immunexpress Group
InDevR
Ingen Biosciences SA
Intelligent Medical Devices, Inc. (IMDx)
IQuum Inc.
Miacom Diagnostics GmbH
MicroPhage, Inc.
Mobidiag Ltd
Molecular Detection Inc. (MDI)
Molzym GmbH & Co. KG
Myconostica
nanoMR Inc.
NetBio
PathGEN Dx Pte. Ltd.
PathoGene
Pathogenica
SIRS-Lab
T2 Biosystems

CHAPTER TWENTY SIX: BLOOD BANK SPECIALISTS
AbSorber AB
AXO Science
GMS Biotech
Grifols, S.A.
Immucor, Inc.
Progenika Inc.

CHAPTER TWENTY SEVEN: COMPANIES SPECILAIZING IN CIRCULATING TUMOR CELLS
ApoCell, Inc.
Biocept, Inc.
Clearbridge BioMedics
Cynvenio Biosystems, Inc.
On-Q-ity
RareCyte, Inc.
ScreenCell
Veridex, LLC

CHAPTER TWENTY EIGHT: COMPANY PROFILES: HISTOLOGY
SPECIALISTS
Advanced Cell Diagnostics
Biocare Medical, LLC
ChipDX, LLC
Cymogen Dx, LLC
Dako A/S

Alliances
Companion Diagnostics


Horizon Discovery Ltd
HTG Molecular Diagnostics

Automation


Mitomics Inc.
Norchip

CHAPTER TWENTY NINE: COMPANY PROFILES: SELECTED TEST SERVICE PROVIDERS
23andMe
Agendia BV

Market Expansion
Product News


AltheaDx Diagnostics, Inc.
Ambry Genetics
Aria Diagnostics, Inc. (formerly Ariosa Diagnostics)
ARUP Laboratories
AssureRx Health, Inc.
Avesthagen Limited
Bio-Reference Laboratories, Inc. (BRLI)
bioTheranostics
Bostwick Laboratories
CardioDx, Inc.
Caris Life Sciences
Castle Biosciences Inc.
CBLPath
Chronix Biomedical Inc.
Clarient Inc.
CombiMatrix Molecular Diagnostics, Inc.
Complete Genomics
Crescendo Bioscience, Inc.
deCode genetics ehf

Gene Variants


DermaGenoma, Inc.
Diagnósticos da América (DASA)
Diatherix Laboratories Inc.
EXACT Sciences Corporation
Exosome Diagnostics
Genelex Corporation
Genetadi Biotech SL
Genomic Health, Inc.

Service Spin off
Expansion
Sequencing
Information Technology


Genoptix Medical Laboratory
GenoVive LLC
Inostics GmbH
IntegraGen SA
Interleukin Genetics, Inc.
Knome, Inc.
Lab21 Limited

Services
Products Division
Expansion


Laboratory Corporation of America Holdings (LabCorp)
LifeCodexx AG
Lineagen Inc.
Lumigenix
Mayo Medical Laboratories
MDxHealth SA (formerly Oncomethylome Sciences)
Medical Diagnostic Laboratories L.L.C. (MDL)
Myriad Genetics, Inc

Alliances
Test Information
Patent Issues


Natera Inc.
Navigenics
NewGene
Pathway Genomics
Pathwork Diagnostics
PGXL Laboratories
Precision Therapeutics
Prometheus Laboratories Inc.

Patent Issues


Quest Diagnostics

Information Technology


Ridge Diagnostics, Inc.
Rosetta Genomics Ltd.
Rules-Based Medicine, Inc. (RBM)
Sequenom Inc.

Sequenom Center for Molecular Medicine
Market Expansion
Prenatal Patent
Genetic Analysis Products


Sequenta, Inc.
Signal Genetics
Sonic Healthcare
SureGene, LLC
Veracyte. Inc.
Verinata Health, Inc.
XDx Inc. – Expression Diagnostics


To order this report:
In_Vitro_Diagnostic Industry:
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)

_______________________
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
Whether you're a startup or a 100 year old enterprise, the Internet of Things offers a variety of new capabilities for your business. IoT style solutions can help you get closer your customers, launch new product lines and take over an industry. Some companies are dipping their toes in, but many have already taken the plunge, all while dramatic new capabilities continue to emerge. In his session at Internet of @ThingsExpo, Reid Carlberg, Senior Director, Developer Evangelism at salesforce.com, to discuss real-world use cases, patterns and opportunities you can harness today.
The Internet of Things (IoT) is going to require a new way of thinking and of developing software for speed, security and innovation. This requires IT leaders to balance business as usual while anticipating for the next market and technology trends. Cloud provides the right IT asset portfolio to help today’s IT leaders manage the old and prepare for the new. Today the cloud conversation is evolving from private and public to hybrid. This session will provide use cases and insights to reinforce the value of the network in helping organizations to maximize their company’s cloud experience.
Cultural, regulatory, environmental, political and economic (CREPE) conditions over the past decade are creating cross-industry solution spaces that require processes and technologies from both the Internet of Things (IoT), and Data Management and Analytics (DMA). These solution spaces are evolving into Sensor Analytics Ecosystems (SAE) that represent significant new opportunities for organizations of all types. Public Utilities throughout the world, providing electricity, natural gas and water, are pursuing SmartGrid initiatives that represent one of the more mature examples of SAE. We have spoken with, or attended presentations from, utilities in the United States, South America, Asia and Europe. This session will provide a look at the CREPE drivers for SmartGrids and the solution spaces used by SmartGrids today and planned for the near future. All organizations can learn from SmartGrid’s use of Predictive Maintenance, Demand Prediction, Cloud, Big Data and Customer-facing Dashboards...
All major researchers estimate there will be tens of billions devices – computers, smartphones, tablets, and sensors – connected to the Internet by 2020. This number will continue to grow at a rapid pace for the next several decades. With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo in Silicon Valley. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be!
Noted IoT expert and researcher Joseph di Paolantonio (pictured below) has joined the @ThingsExpo faculty. Joseph, who describes himself as an “Independent Thinker” from DataArchon, will speak on the topic of “Smart Grids & Managing Big Utilities.” Over his career, Joseph di Paolantonio has worked in the energy, renewables, aerospace, telecommunications, and information technology industries. His expertise is in data analysis, system engineering, Bayesian statistics, data warehouses, business intelligence, data mining, predictive methods, and very large databases (VLDB). Prior to DataArchon, he served as a VP and Principal Analyst with Constellation Group. He is a member of the Boulder (Colo.) Brain Trust, an organization with a mission “to benefit the Business Intelligence and data management industry by providing pro bono exchange of information between vendors and independent analysts on new trends and technologies and to provide vendors with constructive feedback on their of...
Software AG helps organizations transform into Digital Enterprises, so they can differentiate from competitors and better engage customers, partners and employees. Using the Software AG Suite, companies can close the gap between business and IT to create digital systems of differentiation that drive front-line agility. We offer four on-ramps to the Digital Enterprise: alignment through collaborative process analysis; transformation through portfolio management; agility through process automation and integration; and visibility through intelligent business operations and big data.
There will be 50 billion Internet connected devices by 2020. Today, every manufacturer has a propriety protocol and an app. How do we securely integrate these "things" into our lives and businesses in a way that we can easily control and manage? Even better, how do we integrate these "things" so that they control and manage each other so our lives become more convenient or our businesses become more profitable and/or safe? We have heard that the best interface is no interface. In his session at Internet of @ThingsExpo, Chris Matthieu, Co-Founder & CTO at Octoblu, Inc., will discuss how these devices generate enough data to learn our behaviors and simplify/improve our lives. What if we could connect everything to everything? I'm not only talking about connecting things to things but also systems, cloud services, and people. Add in a little machine learning and artificial intelligence and now we have something interesting...
Last week, while in San Francisco, I used the Uber app and service four times. All four experiences were great, although one of the drivers stopped for 30 seconds and then left as I was walking up to the car. He must have realized I was a blogger. None the less, the next car was just a minute away and I suffered no pain. In this article, my colleague, Ved Sen, Global Head, Advisory Services Social, Mobile and Sensors at Cognizant shares his experiences and insights.
We are reaching the end of the beginning with WebRTC and real systems using this technology have begun to appear. One challenge that faces every WebRTC deployment (in some form or another) is identity management. For example, if you have an existing service – possibly built on a variety of different PaaS/SaaS offerings – and you want to add real-time communications you are faced with a challenge relating to user management, authentication, authorization, and validation. Service providers will want to use their existing identities, but these will have credentials already that are (hopefully) irreversibly encoded. In his session at Internet of @ThingsExpo, Peter Dunkley, Technical Director at Acision, will look at how this identity problem can be solved and discuss ways to use existing web identities for real-time communication.
Can call centers hang up the phones for good? Intuitive Solutions did. WebRTC enabled this contact center provider to eliminate antiquated telephony and desktop phone infrastructure with a pure web-based solution, allowing them to expand beyond brick-and-mortar confines to a home-based agent model. It also ensured scalability and better service for customers, including MUY! Companies, one of the country's largest franchise restaurant companies with 232 Pizza Hut locations. This is one example of WebRTC adoption today, but the potential is limitless when powered by IoT. Attendees will learn real-world benefits of WebRTC and explore future possibilities, as WebRTC and IoT intersect to improve customer service.
From telemedicine to smart cars, digital homes and industrial monitoring, the explosive growth of IoT has created exciting new business opportunities for real time calls and messaging. In his session at Internet of @ThingsExpo, Ivelin Ivanov, CEO and Co-Founder of Telestax, will share some of the new revenue sources that IoT created for Restcomm – the open source telephony platform from Telestax. Ivelin Ivanov is a technology entrepreneur who founded Mobicents, an Open Source VoIP Platform, to help create, deploy, and manage applications integrating voice, video and data. He is the co-founder of TeleStax, an Open Source Cloud Communications company that helps the shift from legacy IN/SS7 telco networks to IP-based cloud comms. An early investor in multiple start-ups, he still finds time to code for his companies and contribute to open source projects.
The Internet of Things (IoT) promises to create new business models as significant as those that were inspired by the Internet and the smartphone 20 and 10 years ago. What business, social and practical implications will this phenomenon bring? That's the subject of "Monetizing the Internet of Things: Perspectives from the Front Lines," an e-book released today and available free of charge from Aria Systems, the leading innovator in recurring revenue management.
The Internet of Things will put IT to its ultimate test by creating infinite new opportunities to digitize products and services, generate and analyze new data to improve customer satisfaction, and discover new ways to gain a competitive advantage across nearly every industry. In order to help corporate business units to capitalize on the rapidly evolving IoT opportunities, IT must stand up to a new set of challenges.
There’s Big Data, then there’s really Big Data from the Internet of Things. IoT is evolving to include many data possibilities like new types of event, log and network data. The volumes are enormous, generating tens of billions of logs per day, which raise data challenges. Early IoT deployments are relying heavily on both the cloud and managed service providers to navigate these challenges. In her session at 6th Big Data Expo®, Hannah Smalltree, Director at Treasure Data, to discuss how IoT, Big Data and deployments are processing massive data volumes from wearables, utilities and other machines.
P2P RTC will impact the landscape of communications, shifting from traditional telephony style communications models to OTT (Over-The-Top) cloud assisted & PaaS (Platform as a Service) communication services. The P2P shift will impact many areas of our lives, from mobile communication, human interactive web services, RTC and telephony infrastructure, user federation, security and privacy implications, business costs, and scalability. In his session at Internet of @ThingsExpo, Erik Lagerway, Co-founder of Hookflash, will walk through the shifting landscape of traditional telephone and voice services to the modern P2P RTC era of OTT cloud assisted services.
While great strides have been made relative to the video aspects of remote collaboration, audio technology has basically stagnated. Typically all audio is mixed to a single monaural stream and emanates from a single point, such as a speakerphone or a speaker associated with a video monitor. This leads to confusion and lack of understanding among participants especially regarding who is actually speaking. Spatial teleconferencing introduces the concept of acoustic spatial separation between conference participants in three dimensional space. This has been shown to significantly improve comprehension and conference efficiency.
The Internet of Things is tied together with a thin strand that is known as time. Coincidentally, at the core of nearly all data analytics is a timestamp. When working with time series data there are a few core principles that everyone should consider, especially across datasets where time is the common boundary. In his session at Internet of @ThingsExpo, Jim Scott, Director of Enterprise Strategy & Architecture at MapR Technologies, will discuss single-value, geo-spatial, and log time series data. By focusing on enterprise applications and the data center, he will use OpenTSDB as an example to explain some of these concepts including when to use different storage models.
SYS-CON Events announced today that Gridstore™, the leader in software-defined storage (SDS) purpose-built for Windows Servers and Hyper-V, will exhibit at SYS-CON's 15th International Cloud Expo®, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Gridstore™ is the leader in software-defined storage purpose built for virtualization that is designed to accelerate applications in virtualized environments. Using its patented Server-Side Virtual Controller™ Technology (SVCT) to eliminate the I/O blender effect and accelerate applications Gridstore delivers vmOptimized™ Storage that self-optimizes to each application or VM across both virtual and physical environments. Leveraging a grid architecture, Gridstore delivers the first end-to-end storage QoS to ensure the most important App or VM performance is never compromised. The storage grid, that uses Gridstore’s performance optimized nodes or capacity optimized nodes, starts with as few a...
The Transparent Cloud-computing Consortium (abbreviation: T-Cloud Consortium) will conduct research activities into changes in the computing model as a result of collaboration between "device" and "cloud" and the creation of new value and markets through organic data processing High speed and high quality networks, and dramatic improvements in computer processing capabilities, have greatly changed the nature of applications and made the storing and processing of data on the network commonplace. These technological reforms have not only changed computers and smartphones, but are also changing the data processing model for all information devices. In particular, in the area known as M2M (Machine-To-Machine), there are great expectations that information with a new type of value can be produced using a variety of devices and sensors saving/sharing data via the network and through large-scale cloud-type data processing. This consortium believes that attaching a huge number of devic...
Innodisk is a service-driven provider of industrial embedded flash and DRAM storage products and technologies, with a focus on the enterprise, industrial, aerospace, and defense industries. Innodisk is dedicated to serving their customers and business partners. Quality is vitally important when it comes to industrial embedded flash and DRAM storage products. That’s why Innodisk manufactures all of their products in their own purpose-built memory production facility. In fact, they designed and built their production center to maximize manufacturing efficiency and guarantee the highest quality of our products.